NXL has 36-month beta value of 3.91. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NXL is 9.82M, and currently, short sellers hold a 6.34% ratio of that float. The average trading volume of NXL on December 05, 2024 was 1.62M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NXL) stock’s latest price update
Nexalin Technology Inc (NASDAQ: NXL)’s stock price has plunge by -5.30relation to previous closing price of 4.15. Nevertheless, the company has seen a -7.96% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-26 that Report Highlights Nexalin’s Unique Non-Invasive Solution Addressing Deep Brain Dysfunction, Positioned to Revolutionize Mental Health Treatment Report Highlights Nexalin’s Unique Non-Invasive Solution Addressing Deep Brain Dysfunction, Positioned to Revolutionize Mental Health Treatment
NXL’s Market Performance
Nexalin Technology Inc (NXL) has experienced a -7.96% fall in stock performance for the past week, with a 37.89% rise in the past month, and a 375.10% rise in the past quarter. The volatility ratio for the week is 8.61%, and the volatility levels for the past 30 days are at 15.67% for NXL. The simple moving average for the last 20 days is 0.07% for NXL stock, with a simple moving average of 170.07% for the last 200 days.
NXL Trading at 60.74% from the 50-Day Moving Average
After a stumble in the market that brought NXL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.47% of loss for the given period.
Volatility was left at 15.67%, however, over the last 30 days, the volatility rate increased by 8.61%, as shares surge +31.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +495.08% upper at present.
During the last 5 trading sessions, NXL fell by -7.73%, which changed the moving average for the period of 200-days by +1,042.03% in comparison to the 20-day moving average, which settled at $3.93. In addition, Nexalin Technology Inc saw 870.85% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NXL starting from Owens David, who purchase 500 shares at the price of $2.19 back on Oct 28 ’24. After this action, Owens David now owns 148,293 shares of Nexalin Technology Inc, valued at $1,095 using the latest closing price.
Owens David, the Chief Medical Officer of Nexalin Technology Inc, purchase 1,000 shares at $0.95 during a trade that took place back on Aug 13 ’24, which means that Owens David is holding 147,793 shares at $950 based on the most recent closing price.
Stock Fundamentals for NXL
Current profitability levels for the company are sitting at:
- -40.13 for the present operating margin
- -5.73 for the gross margin
The net margin for Nexalin Technology Inc stands at -34.27. The total capital return value is set at -1.31. Equity return is now at value -135.57, with -114.63 for asset returns.
Currently, EBITDA for the company is -5.69 million with net debt to EBITDA at 0.01. When we switch over and look at the enterprise to sales, we see a ratio of 313.74. The receivables turnover for the company is 10.68for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.39.
Conclusion
To put it simply, Nexalin Technology Inc (NXL) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
